The company's value has been at its all time high in the past month. Definitely good enough for people to take profit. :-)
Printable View
The company's value has been at its all time high in the past month. Definitely good enough for people to take profit. :-)
There has been a lot of capital issued since the $1.50 mark. The last cash issue was at 10 cents in December last year. Shares on issue were 318 million 5 years ago and are 724 million now. It was around that time that they started doing user programs in Singapore, hopefully that will become commercial this year. Last year Australia/Singapore combined only had a third of the tests of NZ, so potentially there will be useful gains there.
I'm new here, so haven't got a handle on the journey yet, but one would hope those capital raises where put to good use and the underlying value of the company is considerably higher than it was in 2014, even if it's not fully recognised in the share price... What's the general consensus there?
Indeed, Tan Tock Seng was the first hospital from Singapore signing the agreement with PEB for the user program.
It was announced around the time when the user program for KP commenced in 2015.
I'll bet "Tan Tock Seng" would appear in the next announcement this year to bring PEB back to all-time high :-)